Skip to Content

Recordati SpA Az nom Post raggruppamento RCDTF Stock Quote

| Rating as of


Last close prices updated as of Dec 29, 2022, 1:26 PM EST | USD
  • Last Close 40.93
  • Sector Healthcare
  • Industry Drug Manufacturers - General
  • Investment Style Mid Blend
  • Day Range 40.93  –  40.93
  • Year Range 36.00  –  63.96
  • Market Cap 8.4071 Bil
  • Volume / Avg 58,168.0 /  17,412.7
  • Price / Sales 4.37
  • Price / Book 4.81
  • Forward Div Yield 2.77%
  • Trailing Div Yield 2.74%

Morningstar‘s Stock Analysis RCDTF

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics RCDTF

Company Profile RCDTF

Business Description

Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth strategy. The vast majority of the company's revenue is generated in Italy, followed by France and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment, which includes the production of active ingredients.

Via Matteo Civitali 1
MIlan, 20148, ITA
Industry Drug Manufacturers - General
Employees 4,303

FAQs for Recordati SpA Az nom Post raggruppamento Stock

No. RCDTF does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

RCDTF’s market cap is 8.41 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

RCDTF’s stock style is Mid Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

RCDTF’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare RCDTF’s historical performance against its industry peers and the overall market.